Cargando…
Severe immune thrombocytopenia induced by nivolumab in a patient with metastatic renal cell carcinoma
In the Checkmate-025 trial, nivolumab treatment prolonged overall survival among patients with previously treated advanced renal cell carcinoma (RCC) compared with treatment with everolimus. Although effective, nivolumab is associated with immune-related adverse events (irAEs). However, the occurren...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256289/ https://www.ncbi.nlm.nih.gov/pubmed/32489885 http://dx.doi.org/10.1016/j.eucr.2020.101128 |